Egusquiaguirre Susana P. について
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215; Departments of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, United States について
Liu Suhu について
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215; Departments of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, United States について
Tosic Isidora について
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215; Departments of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, United States について
Jiang Kevin について
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215; Departments of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, United States について
Walker Sarah R. について
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215; Departments of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, United States について
Nicolais Maria について
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215; Departments of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, United States について
Saw Tzuen Yih について
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215; Departments of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, United States について
Xiang Michael について
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215; Departments of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, United States について
Bartel Katarina について
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215; Departments of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, United States について
Nelson Erik A. について
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215; Departments of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, United States について
Frank David A. について
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215; Departments of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, United States について
Neoplasia について
ヒト について
腫瘍細胞 について
転写因子 について
病因 について
遺伝子発現 について
乳房腫瘍 について
遺伝子サイレンシング について
遺伝子 について
クローン について
相互作用 について
ターゲティング について
タンパク質 について
バイオマーカー について
RNA干渉 について
補因子 について
腫ようの化学・生化学・病理学 について
細胞生理一般 について
発癌性 について
転写因子 について
STAT3 について
補因子 について